Skip to main content

Share story

AI

Anthropic publishes research measuring real-world autonomy of AI agents including Claude Code session lengths

Two stylized hands reaching toward each other with connecting node points Image: Primary
Anthropic published research analyzing millions of human-agent interactions across its Claude Code product and public API. The study used a privacy-preserving tool to assess how much autonomy users grant agents in practice. The research found that Claude Code is working autonomously for longer periods. Among the longest-running sessions, the length of time before stopping nearly doubled in three months from under 25 minutes to over 45 minutes. The increase occurred smoothly across model releases. Experienced users auto-approved more frequently. Full auto-approve sessions rose from roughly 20 percent among new users to over 40 percent as users gained experience. On the most complex tasks, Claude Code stopped to ask for clarification more than twice as often as humans interrupted it. Most agent actions on the public API remained low-risk and reversible. Software engineering accounted for nearly 50 percent of agentic activity. Emerging usage appeared in healthcare, finance and cybersecurity, though not yet at scale. Anthropic concluded that effective oversight of agents will require new forms of post-deployment monitoring infrastructure and new human-AI interaction paradigms.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Anthropic and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.